Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted alpha therapy with 213Bi.
Morgenstern A, Bruchertseifer F, Apostolidis C. Morgenstern A, et al. Among authors: apostolidis c. Curr Radiopharm. 2011 Oct;4(4):295-305. doi: 10.2174/1874471011104040295. Curr Radiopharm. 2011. PMID: 22202152 Review.
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth.
Morgenstern A, Apostolidis C, Kratochwil C, Sathekge M, Krolicki L, Bruchertseifer F. Morgenstern A, et al. Among authors: apostolidis c. Curr Radiopharm. 2018;11(3):200-208. doi: 10.2174/1874471011666180502104524. Curr Radiopharm. 2018. PMID: 29732998 Free PMC article. Review.
Supply and Clinical Application of Actinium-225 and Bismuth-213.
Morgenstern A, Apostolidis C, Bruchertseifer F. Morgenstern A, et al. Among authors: apostolidis c. Semin Nucl Med. 2020 Mar;50(2):119-123. doi: 10.1053/j.semnuclmed.2020.02.003. Epub 2020 Feb 21. Semin Nucl Med. 2020. PMID: 32172796 Free PMC article. Review.
First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT.
Rathke H, Bruchertseifer F, Kratochwil C, Keller H, Giesel FL, Apostolidis C, Haberkorn U, Morgenstern A. Rathke H, et al. Among authors: apostolidis c. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):311-312. doi: 10.1007/s00259-020-04875-y. Epub 2020 May 28. Eur J Nucl Med Mol Imaging. 2021. PMID: 32468252 No abstract available.
Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity.
Kratochwil C, Apostolidis L, Rathke H, Apostolidis C, Bicu F, Bruchertseifer F, Choyke PL, Haberkorn U, Giesel FL, Morgenstern A. Kratochwil C, et al. Among authors: apostolidis c. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):54-63. doi: 10.1007/s00259-021-05474-1. Epub 2021 Aug 26. Eur J Nucl Med Mol Imaging. 2021. PMID: 34448031 Free PMC article.
²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience.
Kratochwil C, Giesel FL, Bruchertseifer F, Mier W, Apostolidis C, Boll R, Murphy K, Haberkorn U, Morgenstern A. Kratochwil C, et al. Among authors: apostolidis c. Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2106-19. doi: 10.1007/s00259-014-2857-9. Epub 2014 Jul 29. Eur J Nucl Med Mol Imaging. 2014. PMID: 25070685 Free PMC article.
109 results